pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
Endpoints·Jul 17·1 min read
save

Zealand Pharma appoints former Lilly executive as US marketing head

Jul 17, 2026·read at Endpoints ↗Neutral

Silvia Luque announced on LinkedIn that she will lead US marketing for Zealand Pharma. The appointment follows a 13-year tenure at Eli Lilly, where she held several roles in the company's obesity franchise.

During her time at Lilly, Luque gained experience in product strategy, launch planning and cross-functional leadership, positioning her to drive Zealand's US commercial efforts for its pipeline.

In a separate move, biotech Bexorg named a new chief scientific officer from Biohaven, underscoring the company's focus on expanding its scientific leadership.

source

This writeup was produced by pharmadog from original reporting by Endpoints.

Original headline: “Zealand Pharma gets its US marketing leader from Lilly; Bexorg turns to Biohaven for CSO hire”

read at Endpoints ↗
95 words · retrieved Jul 17
sharex / twitterlinkedin

comments(0)

5-min edit window · permanent after that
sign in to leave a comment · permanent archive after 5 minutes
no comments yet — first sniff?

companies & drugs in this story

companies
LILLY4ZEALAND PHARMA3ELI LILLY CO2
drugs
Obesity2
topics
Obesity2

related stories

  • 6d agoWhy Roche is 'really excited' about a UCN2 analog for obesity after seeing preclinical dataFierce Biotech
  • Aug 27Myriad catalysts on deck for obesity’s brightest stars as market continues to accelerateBioSpace
  • Aug 24Roche commits to lean-mass preservation with Hanmi obesity dealBioPharma Dive
  • Aug 24Roche pens $2.5B pact for Hanmi’s clinical-stage obesity drug targeting less-explored mechanismFierce Biotech
  • Jul 23Chutes & Ladders—Biogen R&D vet gets in FormationFierce Biotech